Abstract
A new series of anthracene-9, 10-dione derivatives have been synthesized to increase cytotoxic activity against human papillomavirus (HPV) positive cancer cell line, CaSki. The highest cytotoxicity was achieved by 4-(benzylamino)-9,10-dioxo-4a,9,9a,10-tetrahydroanthracen-1-yl 4-ethylbenzenesulfonate (5) with the inhibitory concentration 50 (IC50) of 0.3 μM which is 20 times lower than that of cisplatin (CDDP; IC50 = 8.0 μM). The toxicity against non-cancerous cell line, WI-38, was low with the IC50 > 10 μM. Treatment with this compound resulted in decreasing HPV E6 expression. Furthermore, increasing p53 and decreasing Bcl-2 expression were noted. Cell cycle profiles revealed an accumulation of cells in the G2/M phase.
Keywords:
10-Dione; Anthracene-9; Apoptosis; Cell cycle; Cervical cancer; HPV E6; p53.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anthraquinones / chemical synthesis
-
Anthraquinones / chemistry
-
Anthraquinones / pharmacology*
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Apoptosis / drug effects*
-
Cell Cycle / drug effects
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Humans
-
Models, Molecular
-
Molecular Structure
-
Oncogene Proteins, Viral / biosynthesis*
-
Oncogene Proteins, Viral / deficiency
-
Oncogene Proteins, Viral / genetics
-
Repressor Proteins / biosynthesis*
-
Repressor Proteins / deficiency
-
Repressor Proteins / genetics
-
Structure-Activity Relationship
Substances
-
Anthraquinones
-
Antineoplastic Agents
-
E6 protein, Human papillomavirus type 16
-
Oncogene Proteins, Viral
-
Repressor Proteins
-
9,10-anthraquinone